Skip to Content
Merck
CN
  • Adipose‑derived stem cells and hyaluronic acid based gel compatibility, studied in vitro.

Adipose‑derived stem cells and hyaluronic acid based gel compatibility, studied in vitro.

Molecular medicine reports (2017-07-22)
Jiayan Guo, Shu Guo, Yuxin Wang, Yanqiu Yu
ABSTRACT

Minimally invasive aesthetic and cosmetic procedures have increased in popularity. Injectable dermal fillers provide soft tissue augmentation, improve facial rejuvenation and wrinkles, and correct tissue defects. To investigate the use of adipose‑derived stem cells integrated with a hyaluronic acid based gel as a dermal filler, the present study used cytotoxicity studies, proliferation studies, adipogenic and osteogenic differentiation, apoptosis assays and scanning electron microscopy. Although hyaluronic acid induced low levels of apoptosis in adipose‑derived stem cells, its significantly promoted proliferation of adipose‑derived stem cells. Hyaluronic acid demonstrates little toxicity against adipose‑derived stem cells. Adipose‑derived stem cells were able to differentiate into adipocytes and osteoblasts. Furthermore, scanning electron microscopy revealed that adipose‑derived stem cells maintained intact structures on the surface of hyaluronic acid as well as in it, and demonstrated abundant cell attachments. The present study demonstrated the compatibility of adipose‑derived stem cells and hyaluronic acid based gels in vitro.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Monoclonal Anti-CD29-FITC antibody produced in mouse, clone MEM-101A, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-CD45-FITC antibody produced in mouse, clone MEM-28, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
Monoclonal Anti-CD11b-FITC antibody produced in mouse, clone MEM-174, purified immunoglobulin, buffered aqueous solution